HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease.

AbstractBACKGROUND/AIMS:
Cystic epithelia in polycystic kidney disease display features similar to malignant cells. Thiazolidinediones have been shown to have anti-neoplastic properties, therefore we tested the hypothesis that pioglitazone reduces cyst formation, improves renal function, and prolongs survival in a mouse model of polycystic kidney disease.
METHODS:
PC-Pkd1-KO mice, which have homozygous mutations of the Pkd1 gene in principal cells, were used. On the day after giving birth, mothers were fed standard mouse chow with or without pioglitazone (30 mg/kg chow). After weaning, the assigned diet was continued. At 1 month of age, blood pressure was measured and animals were sacrificed to determine kidney weight, body weight, and serum urea. Kidneys were evaluated for proliferation using Ki-67, apoptosis using TUNEL analysis, and cyst number using MRI. Survival was observed.
RESULTS:
Pioglitazone did not alter renal function, cell proliferation, apoptosis, or cyst formation in animals with polycystic kidney disease, however it did increase survival. Pioglitazone reduced blood pressure in PC-Pkd1-KO, but not in controls.
CONCLUSION:
These findings suggest that pioglitazone may have a unique antihypertensive effect in polycystic kidney disease, and that such an effect may promote improved survival.
AuthorsK L Raphael, K A Strait, P K Stricklett, B C Baird, K Piontek, G G Germino, D E Kohan
JournalAmerican journal of nephrology (Am J Nephrol) Vol. 30 Issue 5 Pg. 468-73 ( 2009) ISSN: 1421-9670 [Electronic] Switzerland
PMID19776560 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 S. Karger AG, Basel.
Chemical References
  • Hypoglycemic Agents
  • TRPP Cation Channels
  • Thiazolidinediones
  • polycystic kidney disease 1 protein
  • Pioglitazone
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Disease Models, Animal
  • Hypertension, Renal (drug therapy, mortality, pathology)
  • Hypoglycemic Agents (pharmacology)
  • Kaplan-Meier Estimate
  • Kidney (drug effects, pathology, physiology)
  • Mice
  • Mice, Knockout
  • Pioglitazone
  • Polycystic Kidney Diseases (drug therapy, mortality, pathology)
  • TRPP Cation Channels (genetics)
  • Thiazolidinediones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: